Terms: = Prostate cancer AND WHSC1, 7468, O96028, WHS, TRX5, REIIBP, NSD2, MMSET, MGC176638, KIAA1090, FLJ23286 AND Clinical Outcome
2 results:
1. Chromatin activation with H3K36me2 and compartment shift in metastatic castration-resistant prostate cancer.
Kanaoka S; Okabe A; Kanesaka M; Rahmutulla B; Fukuyo M; Seki M; Hoshii T; Sato H; Imamura Y; Sakamoto S; Ichikawa T; Kaneda A
Cancer Lett; 2024 Apr; 588():216815. PubMed ID: 38490329
[TBL] [Abstract] [Full Text] [Related]
2. Lentiviral vector-mediated insertional mutagenesis screen identifies genes that influence androgen independent prostate cancer progression and predict clinical outcome.
Nalla AK; Williams TF; Collins CP; Rae DT; Trobridge GD
Mol Carcinog; 2016 Nov; 55(11):1761-1771. PubMed ID: 26512949
[TBL] [Abstract] [Full Text] [Related]